Citadel Advisors’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-259
Closed -$666K 15128
2022
Q3
$666K Sell
259
-2
-0.8% -$5.11K ﹤0.01% 7849
2022
Q2
$662K Buy
261
+2
+0.8% +$5.07K ﹤0.01% 8014
2022
Q1
$656K Sell
259
-1
-0.4% -$2.52K ﹤0.01% 8733
2021
Q4
$652K Sell
260
-9
-3% -$22.5K ﹤0.01% 9021
2021
Q3
$674K Buy
269
+11
+4% +$27.3K ﹤0.01% 9163
2021
Q2
$638K Buy
258
+44
+21% +$109K ﹤0.01% 9466
2021
Q1
$526K Buy
+214
New +$524K ﹤0.01% 9566

Other funds holding ICU

Citadel Advisors's ICU Position: Q4 2022 in Review

Citadel Advisors sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 259 shares — an estimated $666K sold.

Citadel Advisors first reported a position in ICU in Q1 2021 and held it in 7 quarters. The position peaked at $674K in Q3 2021. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

  • Citadel Advisors reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 259 SeaStar Medical shares in Q4 2022, an estimated $666K.
  • Citadel Advisors first reported a position in SeaStar Medical in Q1 2021 and held it in 7 quarters.
  • Citadel Advisors's SeaStar Medical position peaked at $674K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.